From particles to drug product performance and stability

Webinar
Written By Steven Scott

March 21st 2023

Dr Daniel Markl from CMAC’s Digital Medicines Manufacturing research center (DM² ) co-hosted a webinar as part of a series run by the centre partner, Malvern Panalytical.

In this second webinar by DM², Daniel discussed the interplay between particle properties, formulation, microstructure and stability-related performance changes. He also provided insights into how these characteristics can be exploited to develop digitally driven design processes and how he and his team are doing this in their research for DM² Platform 2: Autonomous MicroScale Manufacturing.

If you missed the original session or wish to remind yourself of the useful learnings shared by Daniel, click below to watch a recording of the full webinar:

Watch Now
Steven Scott

Steven Scott is the founder and Creative Director of TwoFifths Design, a brand, website and animation studio in Edinburgh. He works with public sector, research, university and third sector organisations across Scotland, and has been a Squarespace Circle partner since 2018.

https://twofifths.design
Previous

DM² Newsletter: Edition 3
Next

Time to go digital: digitalisation and AI in pharmaceutical R&D